Dr. David Briscoe
Harvard Medical School, Boston, USA
|
Vascular Endothelial Growth Factor in Acute and Chronic Rejection
|
Dr. Ginny Bumgardner
Ohio State University, Columbus, USA
|
Analysis of a Novel Strategy which Suppresses Aggressive (CD4-Independent) CD8+ T-Cell-Initiated Hepatocyte Rejection
|
Dr. Juan Contreras
University of Alabama, Birmingham, USA
|
Increase of Islet Engraftment by Mobilizing Bone-Marrow-Derived Endothelial Progenitor Cells
|
Prof. Philip Halloran
University of Alberta, Edmonton, Canada
|
Mechanisms of Renal Allograft Rejection
|
Prof. John Kirby
University of Newcastle, Newcastle upon Tyne, UK
|
Therapeutic Elimination of Intraepithelial T Cells: A Strategy to Reduce Epithelial-Mesenchymal Transdifferentiation and Chronic Allograft Dysfunction
|
Dr. Wei-Ping Min
University of Western Ontario, London, Canada
|
Novel Strategy for Inducing Transplant Tolerance by Genetically Modifying Dendritic Cells with siRNA
|
Dr. Jeffrey Schechner
Yale University School of Medicine, New Haven, USA
|
Vascularization of Engineered Human Skin Equivalents
|
Prof. Ann Simpson
University of Technology, Sydney, Australia
|
Correction of Diabetes Using Insulin-Secreting Liver Cells
|
Dr. Peter Terness
University of Heidelberg, Heidelberg, Germany
|
Using the Immunosuppressive IDO Gene for Prevention of Allograft Rejection
|
